Mads Jorgen Nohr Clausen

Presidente en Clausen Controls Holding Ii ApS .

40 años

Health Technology

Finance

Perfil

Mads Jorgen Nohr Clausen is associated with Clausen Controls Holding II ApS as Chairman since 2022 and with MC2 Therapeutics Ltd.
as Director since 2008.

Cargos activos de Mads Jorgen Nohr Clausen

Empresas	Cargo	Inicio
MC2 Therapeutics Ltd. MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005.	Director/Miembro de la Junta	25/06/2008
Clausen Controls Holding Ii ApS Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022.	Presidente	04/05/2022

Todos los cargos activos de Mads Jorgen Nohr Clausen

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mads Jorgen Nohr Clausen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
MC2 Therapeutics Ltd. MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005.	Health Technology
Clausen Controls Holding Ii ApS Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022.	Finance

Ver las conexiones de la empresa